COMPANY PROFILE · UPDATED 18 NOV 2025

Alector

Alector, Inc. operates as a clinical stage biopharmaceutical company. The Company researches and develops novel therapeutics for the treatment of neurodegeneration and other brain disorders. Alector offers its services in the State of…

alector.com ↗

This profile is unclaimed — do you work here? Claim it

Claim it →

Founded: 2013
Headcount: 227
Open roles: 2
Last raised: Post Ipo Debt · Sign in to view

LEADERSHIP

Founders & key people

OPEN ROLES

Hiring at Alector

FUNDING

Capital raised

Total raised

$319,500,000

Investors

GvAbbVieAmgenCasdin CapitalDeerfield Capital ManagementEuclidean CapitalFederated HermesForesite CapitalHercules CapitalLilly Asia VenturesMRL Ventures FundMission Bay CapitalMission BioCapitalNew Leaf Venture PartnersOrbiMed AdvisorsPerceptive AdvisorsPolaris PartnersS32SV Health ManagersTopspin Partners

Funding rounds

Post Ipo Debt
Hercules Capital
$50MNov 13, 2024
Post Ipo Equity
$75MJan 16, 2024
IPO
UndisclosedJan 1, 2019
Series E
GV, New Leaf Venture Partners, SV Health Managers, Foresite Capital, MRL Ventures Fund, AbbVie, Perceptive Advisors, Lilly Asia Ventures, Federated Hermes, Casdin Capital, Amgen, Deerfield Capital Management, S32, Polaris Partners, Euclidean Capital, Mission Bay Capital, OrbiMed Advisors, Mission BioCapital
$133MJul 24, 2018
Series D
SV Health Managers, Polaris Partners, OrbiMed Advisors, MRL Ventures Fund, Topspin Partners, AbbVie, Amgen, GV, Mission Bay Capital
$29.5MJan 6, 2016
Series C
MRL Ventures Fund, OrbiMed Advisors, Polaris Partners, GV, Topspin Partners, Mission Bay Capital
$32MSep 15, 2015

Funding data via Diffbot

Categorized in

Industry

Healthcare & Biotech Biotech & Drug Discovery

Investors

Industries

Medical Organizations Health Care Companies Biotechnology Companies

Tech Stack

Mysql Php Wordpress

LOCATIONS

Where they work

Alector offices

Loading map…

South San Francisco, CA131 Oyster Point Blvd suite 600